drugset / Trial / NCT02054000
Intracoronary Tirofiban on No-Reflow Phenomena
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal of this study was to evaluate the acute effect of intracoronary administration of tirofiban on no-reflow phenomenon in patients with STEMI and occurrence of no-reflow phenomenon undergoing primary percutaneous coronary intervention (PCI).
Timeline
- Start
- 2011-01
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tirofiban | Other / unclassified | 25 ug/kg | Other |
Indications
No indication recorded.